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Polyglycolide/Polylactide-Coated Platinum Coils for Patients
With Ruptured and Unruptured Cerebral Aneurysms
A Single-Center Experience
Italo Linfante, MD; Nabil M. Akkawi, MD; Alain Perlow, MD;
Vincenzo Andreone, MD; Ajay K. Wakhloo, MD, PhD
Background and Purpose—Recanalization of cerebral aneurysm is a limitation of bare platinum coils (BPCs). In a swine
aneurysm model, polyglycolide/polylactide (a polymer)-coated platinum coils (Matrix) accelerated clot fibrosis and
reduced recanalization rate and aneurysmal volume. We aimed to evaluate the safety of Matrix coils in patients with
intracranial aneurysm.
Methods—This is a single-center, prospective study of patients with intracranial aneurysms treated with Matrix alone or
in combination with BPCs. Follow-up evaluation included a 1-month clinical evaluation and a 6- and 12-month clinical
and angiographic examination. Primary adverse events included death, stroke, and permanent neurological deficits.
Results—Between May 2002 and January 2004, 52 patients (range 34 to 79 years of age; 38 females) were treated for 54
aneurysms (size 7.94.6 mm; neck 3.91.5 mm; 26 ruptured). Matrix alone was used in 13 aneurysms. In 39, we used
a combination of Matrix and BPCs. Twenty-one aneurysms had a 6-month follow-up examination (11 Matrix; 10 Matrix
combined with bare platinum), and 11 completed the 12-month follow-up evaluation (Matrix only). Adverse events not
related to the procedure were 2 deaths (ruptured basilar aneurysms) and 1 stroke at day 10 postcoiling secondary to
vasospasm. Procedure-related adverse events were 2 strokes. At 6-month follow-up (n21) evaluation, 2 of 3
recanalizations needed retreatment. At 12-month follow-up (n11), there was no recanalization in patients treated with
Matrix alone and no significant reduction in aneurysmal size.
Conclusions—Polyglycolide/polylactide-coated coils had a satisfactory safety profile. Significant aneurysmal size
reduction after coiling was not observed. (Stroke. 2005;36:1948-1953.)
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Endovascular therapy using detachable coils significantlyimproves outcome compared with traditional surgery in
patients with ruptured and unruptured intracranial aneu-
rysms.1–5 In particular, the International Subarachnoid Aneu-
rysm Trial (ISAT) reported a relative risk reduction of death
or dependency at 1 year of 22.6% versus microsurgical
clipping.3 The main drawback of embolization with bare
platinum coils (BPCs) is aneurysmal recanalization occurring
in up to 40% of patients.6–14
Platinum is a biologically inert material. As such, it
produces a delayed clot organization and no inflammatory
response. This phenomenon may be responsible for aneurysm
recanalization after coil embolization, in particular, in broad-
necked or giant aneurysms.7,12 Several strategies have been
used to reduce the percentage of aneurysms that recanalize,
such as: (1) increased packing density; (2) use of radioactive
coils and coils coated with bioabsorbable polymeric material
(BPM);15,19 (3) cytokines such as growth factors,20 ion
implantation, and protein coating;21 and (4) fibroblast tissue
allografts.11,22 In particular, BPMs can stimulate the cellular
reaction necessary to promote scar formation in the aneu-
rysm. This biological reaction can be controlled by the
composition of the copolymers.
Polymer-coated platinum coils (Matrix; BSC/Target) are
platinum coils covered with a bioabsorbable polymer (90%
polyglycolide, 10% polylactide). The composition of BPM is
similar to surgical suture material. Such material is then
wrapped and attached to a stainless-steel delivery wire.
Murayama et al in a swine model reported reduced rate of
recanalization and a decrease in size of the aneurysmal sac in
aneurysms treated with Matrix.15
We present our clinical and angiographic follow-up data in
patients with ruptured and unruptured intracranial aneurysms
treated with 90% polyglycolide-coated and 10% polylactide-
coated platinum coils (Matrix).
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Patients and Methods
This is a single-center, prospective, safety and feasibility study in
which patients were treated with bioabsorbable polymer (polygly-
colide and polylactide)-coated coils (Matrix) alone or in combination
with BPCs. Inclusion criteria for the study were patients 18 years
of age with either ruptured or unruptured aneurysms. The study was
approved by our institutional review board. Informed consent for the
procedure was obtained by the patient whenever possible or by
the closest family member if the patient was unable to understand the
risks or benefits of the procedure.
Angiographic Procedure
All diagnostic angiograms were discussed with the vascular neuro-
surgeon to decide the best approach to the lesion (ie, endovascular
embolization versus microsurgical clipping). Criteria that would
favor an endovascular approach were: (1) age (50 years old); (2)
size; (3) location (posterior circulation); (4) unruptured; (5) if
ruptured, presence of vasospasm; (6) poor grade; and (7) operator
preference or availability.
Patients underwent general anesthesia for the procedure. Access
was obtained via the common femoral artery in all patients. We used
standard angiographic procedure for coil embolization. Endovascular
treatment was performed on a biplane angiography unit with 3D
capability (Artis; Siemens). A Prowler 14-microcatheter (Cordis
Neurovascular; J&J) over either an Agility 10, 14 (Cordis Neuro-
vascular; J&J), or Synchro 10 or 14 microwire (Boston Scientific/
Target) was advanced through a guiding catheter. The tip of the
microcatheter was positioned in the dome of the aneurysm. Before
coil embolization, dimensions of the aneurysm were obtained in 4
projections, and reconstructions in 3 dimensions were obtained in
most patients. The interventionalists could always choose any other
coil system from the inventory if they believed it would be safer,
more effective, or more appropriate for each coil deposition. We
used the Matrix detachable coil preparation commercially available.
Matrix is a platinum coil covered with a bioabsorbable polymer
(90% polyglycolide, 10% polylactide). The details of the coil
characteristics and the detachment system were described previous-
ly.15,17,18 All aneurysms were densely packed using either Matrix
coils alone or a combination of Guglielmi detachable coils (GDCs;
Boston Scientific/Target) or Detachable Coil System (Cordis Neu-
rovascular; J&J) coils. After the treatment, patients were admitted to
the neurosurgical intensive care unit.
Clinical Evaluation
A neurological examination was performed in all patients at baseline,
immediately after the procedure, and at 6 and 12 months after coil
embolization. The modified Rankin scale was included in the 30-day
and 6-month follow-up evaluations. Primary adverse events included
death and stroke. Secondary adverse events recorded were transient
ischemic attack, need for reintervention, and presence of hematomas.
Residual aneurysmal size was determined by angiography. Medical
histories, procedural reports, and clinical outcomes were recorded in
a prospective database maintained for quality assurance purposes by
the Interventional Neuroradiology Service.
The guideline for stopping the study was an incidence of primary
adverse events that exceeded twice the rate of such events reported
in ISAT and International Study of Unruptured Intracranial Aneu-
rysms (ISUIA).3,5
Aneurysmal Volume
Aneurysmal size was measured after obtaining 4 angiographic
projections. Reconstructions in 3 dimensions were obtained in most
patients. Aneurysmal volume was calculated using the ellipsoid,
cylindrical, spherical, or conical volume equations. Packing density
was calculated as the ratio of coil volume to aneurysmal volume. To
evaluate whether Matrix was able to decrease the aneurysmal size,
we calculated the diameters of the aneurysmal sac in 2 perpendic-
ular angiographic projections. Such measurements were obtained at
baseline and at follow-up angiography. In addition, we calculated
aneurysmal volume using the ellipsoid, cylindrical, spherical, or
conical volume equations. Packing density was calculated as the
ratio of coil volume to aneurysmal volume.
Angiographic Follow-Up
Angiographic follow-up studies were scheduled at 3 months.
Twenty-one aneurysms had a 6-month follow-up examination (11
Matrix; 10 Matrix combined with bare platinum), and 11 completed
the 12-month follow-up evaluation (Matrix only). For comparative
reasons, follow-up studies were performed in same projections as the
pre-embolization angiograms. Anatomic results were classified as
published previously.7,15 In particular, results were divided into 3
classes: (1) complete obliteration; (2) residual neck, defined as the
persistence of any portion of the original neck; and (3) residual
aneurysm, defined as any opacification of the aneurysm sac. At
follow-up angiography, a recurrence was defined as any increase in
the size of the remnant. The recurrence was qualified as major if its
size would require a treatment with coils or a surgical clipping.
Statistical Analysis
Values were expressed as mean and SD. Comparisons between
groups and between aneurysmal volumes were performed with
paired and unpaired Student t test analysis and 2. The significance
level was pre-established at P0.05.
Results
Between May 2002 and January 2004, 52 patients (age range
34 to 79 years; 38 females) were treated for 54 aneurysms
(size 7.94.6 mm; neck 3.871.5 mm; 26 ruptured; Table 1).
Thirteen aneurysms were treated with Matrix alone and the
remaining with a combination of Matrix plus other coils.
Satisfactory coiling of the aneurysm was achieved in all but
3 aneurysms, which were left with minimal contrast filling. In
25% of our cases, a balloon remodeling technique was used
as described previously for safer coil embolization.23,24
Stroke related to the procedure was observed in 2 patients:
1 stroke occurred at day 2 (patient treated with a combination
of matrix and BPCs) and the other at day 21 after emboliza-
tion (Matrix only). Adverse events not related to the proce-
dure were 2 deaths in patients with a rupture basilar tip
aneurysm who had a pre-embolization Hunt and Hess grade
5. There was also 1 stroke at day 10 secondary to severe
vasospasm (Table 1).
Twenty-one aneurysms completed the 3- to 6-month
follow-up evaluation (11 Matrix; 10 Matrix plus other sys-
tems), and 11 completed the 12-month follow-up evaluation
(Matrix only; Figure 1). Overall, there have been no deaths or
aneurysmal rupture during the follow-up period. At 3- to
6-month (n21) angiographic follow-up evaluation, there
was 1 recurrence secondary to insufficient Matrix coil supply.
At the time of follow-up evaluation, a coil embolization of the
remnant aneurysmal sac was successfully accomplished (Fig-
ure 2). There was 1 aneurysm with center filling (treated with
a combination of Matrix and BPC) possibly secondary to
concomitant therapy with aspirin plus clopidogrel for 6
months. One aneurysm showed coil compaction probably
secondary to insufficient packing density.
At the 12-month follow-up (n11; Matrix alone), there
was no recanalization of the treated aneurysms. In the 11
patients treated with Matrix alone, average coil packing
density was 29% (Table 2). Nine patients had unruptured and
4 had ruptured aneurysms. Two patients experienced vaso-
spasm during the initial procedure that improved with tripleH
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therapy. Five patients had residual neck not requiring retreat-
ment (Figure 2). Opening of the aneurysm neck was noted in
only 2 patients. Reduction of aneurysm size was not observed
at 12-month follow-up in patients treated with Matrix alone
(Table 3; Figures 1 and 2).
Discussion
In this preliminary experience, Matrix coils had a satisfactory
safety profile. The procedure led to 1 stroke at day 2 and 1
stroke at day 21 after coil embolization. Adverse events
unrelated to the procedure were 2 deaths in patients with
ruptured basilar artery aneurysms (Hunt and Hess grade 5)
and 1 stroke at day 10 because of severe vasospasm. At
6-month (n21) angiographic follow-up evaluation, there
were 3 aneurysms that recanalized (14.2%). At 12-month
angiographic and clinical follow-up, there were no deaths or
aneurysmal ruptures. A size reduction of aneurysms treated
with Matrix coils alone was not observed.
The exact mechanism by which thrombosis and formation
of neointimal proliferation after coil embolization is not
known.25 Platinum coils elicit a mild biological response
when deployed into an aneurysm.26 Tamatani et al reported
no endothelial proliferation on the BPC surface in an in vitro
study.19 From histopathologic reports on human aneurysms
embolized with GDC, it appears that the intra-aneurysmal
clot undergoes a slow organization.12,19 Therefore, when such
TABLE 1. Demographic Data and Clinical Adverse Events in Patients With Cerebral Aneurysms and Treated With Matrix Coils Only or
a Combination of Matrix and BPCs
Age
(meanSD;
years)
Sex
(Male/
Female)
*Size
Aneurysm
(meanSD;
mm)
Neck
Aneurysm
(meanSD;
mm)
Ruptured/
Unruptured
Aneurysm
Clinical Adverse
Events (Postcoiling)
Follow-Up
Related to
Procedure
Unrelated
to Procedure
Patients (n52; 54
aneurysms)
55.912.9 14/38 7.94.6
S (23), M (20),
L (11)
3.871.5
S (25),
L (29)
26/28 2 2
MatrixBPC (n39;
41 aneurysms)
56.313.9 9/30 8.14.6
S (18), M (16)
L (7)
4.01.65
S (20)
L (21)
22/19 1 stroke at
day 2
1 stroke at
day 10
(vasospasm)
2 deaths (ruptured
basilar aneurysms)
(patients admitted
with grade 5 H&H)
All survived at
3 months;
10 at 6 months
Matrix only (13
aneurysms)
55.19.7 5/8 7.45.1
S (5), M (4)
L (4)
3.591.3
S (5)
L (8)
4/9 1 stroke at
day 21
All at 3 months;
11 at 12 months
P NS† NS‡ NS† NS† NS‡
H&H indicates Hunt and Hess Scale.
For aneurysmal size, S indicates small (5 mm); M, medium (5–10 mm); L, large ( 10 mm or neck).
For aneurysmal neck, S indicates small (4 mm); L, large (4 mm).
*Size is considered the largest diameter of the aneurysm in 2 perpendicular angiographic projections; †analysis based on unpaired Student’s t test; ‡analysis
based on 2.
Figure 1. Case example. 42-year-old
woman with a rupture basilar tip aneu-
rysm. A, Anteroposterior view of the left
vertebral artery (VA) injection. B, Antero-
posterior view of the left VA injection
after embolization with Matrix coils alone
shows mild contrast accumulation at the
base (white arrow). 3-month follow-up
angiogram: nonsubtracted lateral view
shows the coil mass with large gaps
between the coils (white arrow [C] and
subtracted view shows no contrast filling
between the coils because it has most
likely been replaced by connective tissue
(white arrow; D). 12-month follow-up
angiogram: anteroposterior view of the
left VA injection demonstrating coil com-
paction at the neck and no recanalization
of the aneurysm (white arrow; E). There
was no reduction in aneurysmal size
between the pre-embolization and
postembolization angiogram.
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phenomena do not occur, the effect of pulsatile blood flow
against inert platinum causes the coil mass to compact,
leading to eventual aneurysmal recanalization.25,27 For all
these reasons, investigators have explored the use of coils that
promote organization of the initial thrombus such as polymer-
coated coils and radioactive coils.15,16
With regard to polymer-coated coils, it has been reported
that aneurysm thrombosis could be controlled by the compo-
sition of the polymer ratio.28–29 As the polymer degrades, it
produces a mild inflammatory reaction. In a swine model,
Murayama et al showed that Matrix-treated aneurysms pre-
sented an average of 87% of their area as organized thrombus
versus an average of 75% in the aneurysms treated with
BPCs.15 Histologically, bioabsorbable polymer was replaced
by mature connective tissue. The authors reported that mature
scar tissue by the process of wound healing decreases the size
of the aneurysm.
In our small case series of 11 patients treated with matrix
alone, we did not replicate such findings (Table 3; Figures 1
and 2). The experimental observation may be related to less
packing density of the aneurysm in the Matrix group com-
pared with the bare platinum–treated side wall porcine
aneurysm.15
In the present series, we observed individual variation in
the amount of scarring tissue formation after embolization
with Matrix coils. Neointimal growth or “white collar sign”
was seen in 2 patients treated with Matrix coils alone (Figure
2).30 On the other hand, this phenomena may lead to unto-
ward parent artery stenosis or occlusion related to intra-an-
eurysmal clot formation and subsequent fibrosis. Excessive
clot formation leading to stroke was observed in 2 patients.
Fibrosis and subsequent stenosis of the parent arteries adja-
cent to the aneurysm was observed in another case. This
observation needs careful evaluation in a larger cohort of
patients.
Friction and compartmentalization were observed in our
experience. Friction is probably related to the high amount of
polymer (70%) supported by a small central wire (30%) as
designed in the first generation Matrix coils. We hypothesize
that the high percentage of polymer creates an increase in
contact points between the coil and the inner surface of the
catheter. Consequently, the axial force required to advance
the coil is higher. With regard to compartmentalization, the
polymer is braided over the wire, therefore not allowing break
points within the coil to be active. This may result in less
compliance of the coil as it folds against the endothelium of
the aneurysm and other coils.
Regarding recanalization, in 1 patient treated with aspirin
plus clopidogrel, we noted a center-filling defect. We hypoth-
esized that the concurrent treatment of aggressive antiplatelet
regimen may induce recanalization by preventing thrombus
formation.
This preliminary study was not designed to assess efficacy.
The recurrence rate in our small cohort is compatible with any
Figure 2. Case example. 62-year-old
woman with an unruptured left supracli-
noid internal carotid artery (ICA) aneu-
rysm treated with Matrix coils alone. A,
Left magnified oblique view of the left
ICA injection before embolization (black
arrow). B, 3-month follow-up: nonsub-
tracted view of the coil mass showed a
large coil gap between the coils in the
posterior portion of the aneurysmal sac
(white arrow). This resulted in persistent
filling of the aneurysm after coiling with
“dog ear” appearance (C). 12-month
follow-up: left ICA injection in left lateral
oblique view shows no contrast filling
between the coil mass because it has
most likely been replaced by connective
tissue (black arrow; D and E). Nonsub-
tracted (E) and subtracted (F) view of a
left lateral oblique ICA angiogram shows
formation of a membrane at the neck of
the aneurysm (white arrows). There was
no reduction in aneurysmal size between
the pre-embolization and postemboliza-
tion angiogram.
TABLE 2. Aneurysmal Volume, Coil Volume, and Packing
Density of Aneurysms Treated With Matrix Only
Patients
Aneurysm
Volume (mm3)
Coil Volume
(mm3)
Packing Density
(%)
1 157.8 32.9 20.9
2 322.8 82.0 25.4
3 11.10 3.2 28.9
4 58.90 9.6 16.3
5 525.0 144.7 27.5
6 1796.9 315.2 17.5
7 7.6 4.8 63.3
8 13.1 5.2 27.9
9 2280.3 506.6 22.2
10 15.7 6.4 40.9
11 634.4 130.2 20.5
MeanSD 634.4784.6 112.8161.8 29.013.1
Linfante et al Matrix Coils in Patients With Cerebral Aneurysms 1951
 at UNIV MASSACHUSETTS on March 27, 2009 stroke.ahajournals.orgDownloaded from 
hypothesis (success or failure in decreasing recurrences). In
addition, we acknowledge that this pilot study has several
weak points. (1) The total number of aneurysms is small. (2)
Not all patients have long-term angiographic follow-up. (3)
The study does not contain a control group with GDC
procedure alone. (4) A comparison with clinical data on
patients treated with Matrix is not yet available because most
data are available only in an abstract form or in 2 cases
reported recently.30–31
Conclusions
Matrix coil has been the first attempt in using enhanced
inflammatory response to reduce aneurysmal recanalization.
This preliminary experience shows that polymer-coated coils
may be a safe option in patients with ruptured and unruptured
aneurysms. Individual excessive inflammatory response to
Matrix coils resulting in untoward parent artery stenosis or
occlusion may be observed and needs further investigation.
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